Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

Absolute eosinophil count in coronavirus disease 2019 patients: A cross-sectional study in a tertiary care institution of India

Senjuti Dasgupta, Manas Talukdar, Manish Osta, Uma Banerjee.

Background: Sudden deterioration of cases in coronavirus disease 2019 (COVID-19) is one of the most important reasons contributing to deaths. Hence, a cost-effective test is required for early suspicion of COVID-19 cases and triage of patients. The previous studies have already suggested that eosinopenia can be used as a marker of suspicion in COVID-19.

Aims and Objectives: The current study was conducted to find out eosinophil count of blood in COVID-19 patients along with its role to predict severity so that this routine and cost-effective parameter can be utilized for prompt management.

Materials and Methods: This observational cross-sectional study was done on hospitalized COVID-19 adult patients where patients were categorized into moderate and severe cases as per guideline of Government of India. Absolute eosinophil count was compared in these two groups by unpaired t-test to find out its significance.

Results: Out of total 176 cases, 45 (25.5%) were categorized as severe while rest 131 (74.5%) patients were in moderate category of disease. Sixty-three patients (35.70%) had absolute eosinophil count as zero while total 105 patients (59.65%) had absolute eosinopenia (defined as eosinophil count

Key words: Coronavirus Disease 2019; Eosinophil; Absolute Eosinophil Count

Similar Articles

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327

Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era.
Tantisattamo E, Hanna RM, Kalantar-Zadeh K
Current opinion in nephrology and hypertension. 2022; 31(1): 1-5

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Differentiating Human Pluripotent Stem Cells to Vascular Endothelial Cells for Regenerative Medicine, Tissue Engineering, and Disease Modeling.
Bertucci T, Kakarla S, Kim D, Dai G
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 1-12

Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease.
Hernandez-Sapiens MA, Reza-Zaldívar EE, Márquez-Aguirre AL, Gómez-Pinedo U, Matias-Guiu J, Cevallos RR, Mateos-Díaz JC, Sánchez-González VJ, Canales-Aguirre AA
Neural regeneration research. 2022; 17(1): 31-37

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites